Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of...( MIAMI Nov. 26 /- Thomas K. Equels Pre...)

MIAMI, Nov. 26 /PRNewswire/ -- Thomas K. Equels, President and Managing Director of the Equels Law Firm, has been elected to the board of directors for Hemispherx BioPharma, Inc. (Amex: HEB), a Philadelphia-based biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for the treatment of viral and immune-based disorders.

Equels' legal practice is devoted to litigation, with particular emphasis on civil racketeering, business torts and commercial matters. Prior to his board election, Equels served as Hemispherx BioPharma's litigation counsel.

For more than 25 years, Equels has represented national and state governments, and companies in the banking, insurance, aviation, pharmaceutical, construction and development industries. He has extensive experience in complex litigation matters including:

    -- Obtained a $26.8 million judgment in 2008 in a breach of contract
       action against Bear Stearns, for the Delaware Insurance Commissioner,
       related to an insolvent insurance company.
    -- Obtained a $15 million judgment in 2005 against boy band guru Lou
       Pearlman of Trans Continental Records, Inc.
    -- Obtained a $44 million judgment against Manuel Noriega for public money
       he misappropriated from the Republic of Panama.
    -- Recovered more than $100 million misappropriated and money laundered
       overseas by former insiders of a now defunct insurance company being
       liquidated by the State of Delaware's Insurance Commissioner.
    -- Obtained and collected a $10.6 million judgment against the FDIC for
       breach of contract involving a client's purchase of a national mortgage
       company owned by a failed savings and loan.
    -- Prosecuted a bank fraud claim against an international lender, which
       resulted in a jury aw
'/>"/>
SOURCE  Equels Law Firm
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 
Related biology technology :

1. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
2. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
3. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
5. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
6. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
7. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
8. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
9. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
10. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
11. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007